Accès à distance ? S'identifier sur le proxy UCLouvain
Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy
Primary tabs
| Document type | Article de périodique (Journal article) – Article de recherche |
|---|---|
| Publication date | 2018 |
| Language | Anglais |
| Journal information | "Molecular Cancer Therapeutics" - Vol. 17, no.12, p. 2530-2542 (2018) |
| Peer reviewed | yes |
| Publisher | American Association for Cancer Research (AACR) |
| issn | 1535-7163 |
| e-issn | 1538-8514 |
| Publication status | Publié |
| Affiliation | UCL - SSS/DDUV - Institut de Duve |
| Keywords | Cancer Research ; Oncology |
| Links |
| Bibliographic reference | Gomes, Bruno ; Driessens, Gregory ; Bartlett, Derek ; Cai, Danying ; Cauwenberghs, Sandra ; et. al. Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy. In: Molecular Cancer Therapeutics, Vol. 17, no.12, p. 2530-2542 (2018) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/213631 |